Showing results (601-610 of 615) with videos related to

Sort By:
Pageof 62
Annals of the New York Academy of Sciences|July 19, 2001
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effectL Feinstein, B Sandmaier, D Maloney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaW I Bensinger, S D Rowley, T Demirer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?R Storb, W Leisenring, C Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 1996
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recoveryK M Sullivan, J Storek, K J Kopecky, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2009
Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantationR A Nash, M Yunosov, K Abrams, et al.
Bone Marrow Transplantation|August 28, 2003
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantationChien-Shing Chen, M Boeckh, K Seidel, et al.
Pageof 62